During the past decade, Regional Cardiology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 11 clinical trials were completed, i.e. on average, 550% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Cardiology Associates" #1 sponsor was "Abbott Medical Devices" with 8 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored, "Vivek Reddy" with 2 trials sponsored and "Forest Laboratories" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cardiology Associates" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Registrat-Mapi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Regional Cardiology Associates" are "Heart Failure" (7 trials), "Atrial Fibrillation" (3 trials), "Atrial Flutter" (2 trials), "Typical Atrial Flutter" (2 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Regional Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Regional Cardiology Associates" are "Device" (12 trials) and "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Vernakalant Injection 20 mg/mL" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "Azimilide Dihydrochloride" (1 trials), "Blazer® Open-Irrigated Ablation Catheter" (1 trials) and "Boston Scientific Vessix Renal Denervation System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Cardiology Associates" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Regional Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Regional Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".